Enanta Pharmaceuticals (ENTA) Return on Equity [ROE] (2013 - 2026)
Enanta Pharmaceuticals' Return on Equity [ROE] came in at -58.10% for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 48.38 percentage points from -106.48% a year earlier but down 7.12 percentage points from the prior quarter.
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Return on Equity [ROE] (2013 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Enanta Pharmaceuticals' Return on Equity [ROE] was -84.63%, down 17.46 percentage points from FY2024.
- Return on Equity [ROE] has declined in each of the last seven fiscal years, with a five-year change of -76.75 percentage points (FY2020 to FY2025).
- Going back by fiscal year, Return on Equity [ROE] was -67.17% in FY2024 (-17.43 pp), -49.74% in FY2023 (-15.95 pp), -33.79% in FY2022 (-15.31 pp) and -18.48% in FY2021 (-10.60 pp).
- The five-year range for quarterly Return on Equity [ROE] is -113.74% (fiscal Q4 2025) to -22.81% (fiscal Q4 2021).
- Year-over-year, Return on Equity [ROE] has increased for three consecutive quarters, with an average year-over-year change of -3.03 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in fiscal Q3 2026 (a gain of 48.38 percentage points), and the weakest in fiscal Q3 2025 (a drop of 33.27 percentage points).
- Business Quant data shows ENTA's Return on Equity [ROE] at -50.98% (Q2 2026), -74.79% (Q1 2026) and -113.74% (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Enanta Pharmaceuticals | 326.73 Mn | -401.27 Mn | - | -58.10% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -58.10% |
| Mar 31, 2026 | -50.98% |
| Dec 31, 2025 | -74.79% |
| Sep 30, 2025 | -113.74% |
| Jun 30, 2025 | -106.48% |
| Mar 31, 2025 | -93.90% |
| Dec 31, 2024 | -87.21% |
| Sep 30, 2024 | -83.57% |
| Jun 30, 2024 | -73.22% |
| Mar 31, 2024 | -73.60% |
| Dec 31, 2023 | -67.66% |
| Sep 30, 2023 | -58.88% |
| Jun 30, 2023 | -52.07% |
| Mar 31, 2023 | -43.74% |
| Dec 31, 2022 | -38.78% |
| Sep 30, 2022 | -36.93% |
| Jun 30, 2022 | -34.45% |
| Mar 31, 2022 | -30.24% |
| Dec 31, 2021 | -29.34% |
| Sep 30, 2021 | -22.81% |
API Access
Enanta Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();